Russell Investments Group Ltd. raised its stake in Cardinal Health, Inc. (NYSE:CAH – Free Report) by 18.7% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 558,898 shares of the company’s stock after purchasing an additional 88,192 shares during the period. Russell Investments Group Ltd. owned 0.24% of Cardinal Health worth $124,384,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Eurizon Capital SGR S.p.A. grew its position in Cardinal Health by 10.8% in the 3rd quarter. Eurizon Capital SGR S.p.A. now owns 70,583 shares of the company’s stock valued at $15,693,000 after buying an additional 6,870 shares during the last quarter. CENTRAL TRUST Co increased its stake in Cardinal Health by 63.0% in the 3rd quarter. CENTRAL TRUST Co now owns 2,135 shares of the company’s stock valued at $475,000 after purchasing an additional 825 shares in the last quarter. Maryland State Retirement & Pension System raised its holdings in Cardinal Health by 13.5% during the third quarter. Maryland State Retirement & Pension System now owns 14,083 shares of the company’s stock worth $3,133,000 after purchasing an additional 1,670 shares during the last quarter. Ritholtz Wealth Management raised its holdings in Cardinal Health by 13.7% during the third quarter. Ritholtz Wealth Management now owns 35,614 shares of the company’s stock worth $7,924,000 after purchasing an additional 4,287 shares during the last quarter. Finally, UNIVEST FINANCIAL Corp boosted its position in Cardinal Health by 2.7% during the third quarter. UNIVEST FINANCIAL Corp now owns 2,309 shares of the company’s stock worth $514,000 after purchasing an additional 60 shares in the last quarter. Institutional investors and hedge funds own 87.17% of the company’s stock.
Cardinal Health Stock Performance
Shares of NYSE:CAH opened at $281.55 on Monday. The business’s fifty day moving average price is $244.15 and its two-hundred day moving average price is $225.24. The stock has a market cap of $65.08 billion, a PE ratio of 36.42, a price-to-earnings-growth ratio of 2.15 and a beta of 0.53. Cardinal Health, Inc. has a one year low of $180.45 and a one year high of $286.29.
Cardinal Health (NYSE:CAH – Get Free Report) last released its quarterly earnings results on Thursday, November 5th. The company reported $3.26 earnings per share for the quarter, topping the consensus estimate of $2.94 by $0.32. Cardinal Health had a negative return on equity of 102.72% and a net margin of 0.71%. The company had revenue of $67.51 billion during the quarter, compared to the consensus estimate of $66.67 billion. During the same quarter last year, the business posted $2.55 earnings per share. Cardinal Health’s revenue was up 5.5% compared to the same quarter last year. As a group, equities research analysts predict that Cardinal Health, Inc. will post 12.97 earnings per share for the current fiscal year.
Cardinal Health Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 15th. Investors of record on Monday, January 4th will be given a dividend of $0.5158 per share. This represents a $2.06 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date is Monday, January 4th. Cardinal Health’s dividend payout ratio (DPR) is currently 26.65%.
Wall Street Analysts Forecast Growth
Several analysts have weighed in on the company. Robert W. Baird upped their target price on Cardinal Health from $251.00 to $274.00 and gave the company an “outperform” rating in a report on Wednesday, August 12th. Argus lifted their price target on Cardinal Health from $264.00 to $309.00 and gave the stock a “buy” rating in a research note on Thursday. TD Cowen increased their price objective on shares of Cardinal Health from $280.00 to $304.00 and gave the company a “buy” rating in a research note on Monday, November 9th. Citigroup raised their target price on shares of Cardinal Health from $265.00 to $280.00 and gave the company a “buy” rating in a report on Wednesday, August 12th. Finally, Leerink Partners set a $292.00 target price on shares of Cardinal Health in a research report on Tuesday, August 11th. One research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, Cardinal Health currently has an average rating of “Moderate Buy” and an average price target of $279.44.
View Our Latest Analysis on Cardinal Health
Insider Buying and Selling
In other Cardinal Health news, CEO Stephen Mason sold 35,000 shares of the company’s stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $236.40, for a total value of $8,274,000.00. Following the transaction, the chief executive officer directly owned 18,061 shares in the company, valued at approximately $4,269,620.40. This represents a 65.96% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Michelle Greene sold 11,650 shares of the firm’s stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $235.72, for a total transaction of $2,746,138.00. Following the sale, the insider directly owned 10,330 shares in the company, valued at $2,434,987.60. This represents a 53.00% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 210,271 shares of company stock worth $49,626,657 in the last 90 days. 0.12% of the stock is currently owned by corporate insiders.
Cardinal Health Profile
Cardinal Health is a healthcare services and products company that distributes pharmaceuticals and medical supplies. Its customers include pharmacies, hospitals, surgery centers, physician offices and other healthcare providers. The company’s businesses include pharmaceutical distribution and specialty services, as well as the sourcing and distribution of medical and surgical products. Its offerings support areas such as specialty medications, medication management and supply-chain operations. Cardinal Health traces its roots to a wholesale business founded in Ohio in 1971 and later expanded into pharmaceutical distribution.
Featured Stories
- Five stocks we like better than Cardinal Health
- Fossil Just Turned a Profit—Can Its Comeback Survive the Holidays?
- Beaming Up the Backlog: AeroVironment Lands $405M Laser Deal
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.
